Mediators of Inflammation / 2010 / Article / Tab 1 / Clinical Study
Circulating Cytokine Profiles and Their Relationships with Autoantibodies, Acute Phase Reactants, and Disease Activity in Patients with Rheumatoid Arthritis Table 1 Demographic, laboratory, and clinical data for the group of RA patients (
𝑛
=
1
4
0
).
Parameters Quintiles Mean ± SD Q1 (p25) Q2 (Median) Q3 (p75) Range Age (years)
4
8
±
1
2
41 48 56 20–75 Female (%) 115 (82.1) Ethnic origin: Black (%) 111 (87.0) DAS28-CRP
5
.
7
±
1
.
2
4.8 5.9 6.6 2.3–8.0 HDA (
D
A
S
2
8
≥
5
.
1
) (%) 63 (45.0) LDA (
D
A
S
2
8
≥
3
.
2
& <5.1) (%) 62 (44.3) mHAQ-DI
3
.
2
±
1
.
6
2.0 3.5 4.5 0.0–6.0 Disease duration (months)
1
2
±
7
6 10 18 0–25 SJC
1
0
±
6
4 9 14 0–27 X-ray erosions (%) 65/121 (53.7) RF (IU/mL)
4
9
3
±
8
0
3
40 171 579 4–5350 aCCP (U/mL)
6
5
4
±
6
2
1
80 490 1082 2–2431 aMCV (U/mL)
5
9
4
±
6
7
9
104 326 775 16–3088 CRP (mg/L)
2
3
.
0
±
2
.
5
5.1 13.6 30.6 0.3–164 SAA (μ g/mL)
6
1
±
1
2
4
5 16 60 1–882
DAS28: Disease activity score for 28 joints, HDA: High disease activity, LDA: Low disease activity, mHAQ-DI: modified Health assessment questionnaire-disease Index, SJC: Swollen Joint Count, RF: Rheumatoid factor, aCCP: anticyclic citrullinated peptide antibodies, aMCV: Antimodified citrullinated vimentin antibodies, CRP: C-reactive protein, SAA: Serum amyloid A.
